Evidence map›Paper›PMID 26240480›Full record

Trial reportJournal of Korean medical science2015

Predictors of Asthma Control by Stepwise Treatment in Elderly Asthmatic Patients.

Ga-Young Ban, Young-Min Ye, Yunhwan Lee, Jeong-Eun Kim, Young-Hee Nam, Soo-Keol Lee, Joo-Hee Kim, Ki-Suck Jung, Sang-Ha Kim, Hae-Sim Park and 1 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Journal of Korean medical science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Aging, brain-derived neurotrophic factor, and allergen-induced pulmonary responses in mice.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  2. miR-135a inhibits airway inflammatory response in asthmatic mice via regulating JAK/STAT signaling pathway.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Ga-Young BanDepartment of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.
Young-Min YeDepartment of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.
Yunhwan LeeDepartment of Preventive Medicine & Public Health, Ajou University School of Medicine, Suwon, Korea.
Jeong-Eun KimDepartment of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
Young-Hee NamDepartment of Internal Medicine, Dong-A University School of Medicine, Busan, Korea.
Soo-Keol LeeDepartment of Internal Medicine, Dong-A University School of Medicine, Busan, Korea.
Joo-Hee KimDepartment of Internal Medicine, Hallym University School of Medicine, Anyang, Korea.
Ki-Suck JungDepartment of Internal Medicine, Hallym University School of Medicine, Anyang, Korea.
Sang-Ha KimDepartment of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
Hae-Sim ParkDepartment of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.
Premier Researchers Aiming New Era in Asthma and Allergic Diseases (PRANA) Study Group
Ajou University · KRHallym University · KRDong-A University · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The geriatric population is increasing, and asthma severity increases with age. We determined the predictors of asthma control, exacerbation, and the factors that affect asthma-specific quality of life (A-QOL) in elderly asthmatic patients. This was a prospective, multicenter, real-life study for 6 months with stepwise pharmacologic treatment based on the Global Initiative for Asthma (GINA) guideline. A total of 296 asthmatic patients aged ≥ 60 yr were recruited from 5 university centers in Korea. The improved-asthma control group was defined as the group of patients who maintained well-controlled or improved disease and the not-improved asthma control group was defined as the remaining patients. Fewer number of medications for comorbidities (2.8 ± 3.3 in the improved vs. 4.5 ± 4.4 in the control) and higher physical functioning (PF) scale (89.8 ± 14.2 in the improved vs. 82.0 ± 16.4 in the control) were significant predictors in the improved-asthma control group (OR = 0.863, P = 0.004 and OR = 1.028, P = 0.018, respectively). An asthma control test (ACT) score of ≤ 19 at baseline was a significant predictor of asthma exacerbation (OR = 3.938, P = 0.048). Asthma duration (F = 5.656, P = 0.018), ACT score (F = 12.237, P = 0.001) at baseline, and the presence of asthma exacerbation (F = 5.565, P = 0.019) were significant determinants of changes in A-QOL. The number of medications for comorbidities and performance status determined by the PF scale may be important parameters for assessing asthma control in elderly asthmatic patients.

Indexed as

Quality of LifeAgedAged, 80 and overAnti-Asthmatic AgentsAsthmaCritical PathwaysDose-Response Relationship, DrugFemaleGeriatric AssessmentHumansMaleMiddle AgedOutcome Assessment, Health CareReproducibility of ResultsRepublic of KoreaSensitivity and SpecificityAnti-Asthmatic AgentsAsthmaComorbidityControlElderlyPerformance

Identifiers

PMID26240480
PMCPMC4520933
OpenAlexW2142777900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.